Literature DB >> 23607937

Differences between RNA and DNA due to RNA editing in temporal lobe epilepsy.

Heinz Krestel1, Simon Raffel, Marec von Lehe, Caroline Jagella, Susanna Moskau-Hartmann, Albert Becker, Christian E Elger, Peter H Seeburg, Arto Nirkko.   

Abstract

To investigate whether alterations in RNA editing (an enzymatic base-specific change to the RNA sequence during primary transcript formation from DNA) of neurotransmitter receptor genes and of transmembrane ion channel genes play a role in human temporal lobe epilepsy (TLE), this exploratory study analyzed 14 known cerebral editing sites in RNA extracted from the brain tissue of 41 patients who underwent surgery for mesial TLE, 23 with hippocampal sclerosis (MTLE+HS). Because intraoperatively sampled RNA cannot be obtained from healthy controls and the best feasible control is identically sampled RNA from patients with a clinically shorter history of epilepsy, the primary aim of the study was to assess the correlation between epilepsy duration and RNA editing in the homogenous group of MTLE+HS. At the functionally relevant I/V site of the voltage-gated potassium channel Kv1.1, an inverse correlation of RNA editing was found with epilepsy duration (r=-0.52, p=0.01) but not with patient age at surgery, suggesting a specific association with either the epileptic process itself or its antiepileptic medication history. No significant correlations were found between RNA editing and clinical parameters at other sites within glutamate receptor or serotonin 2C receptor gene transcripts. An "all-or-none" (≥95% or ≤5%) editing pattern at most or all sites was discovered in 2 patients. As a secondary part of the study, RNA editing was also analyzed as in the previous literature where up to now, few single editing sites were compared with differently obtained RNA from inhomogenous patient groups and autopsies, and by measuring editing changes in our mouse model. The present screening study is first to identify an editing site correlating with a clinical parameter, and to also provide an estimate of the possible effect size at other sites, which is a prerequisite for power analysis needed in planning future studies.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23607937     DOI: 10.1016/j.nbd.2013.04.006

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  13 in total

1.  Functional Differences Between Two Kv1.1 RNA Editing Isoforms: a Comparative Study on Neuronal Overexpression in Mouse Prefrontal Cortex.

Authors:  Liting Zhang; Zetong Peng; Wenjun Bian; Pingping Zhu; Bin Tang; Wei-Ping Liao; Tao Su
Journal:  Mol Neurobiol       Date:  2021-01-07       Impact factor: 5.590

2.  Altered intrathalamic GABAA neurotransmission in a mouse model of a human genetic absence epilepsy syndrome.

Authors:  Chengwen Zhou; Li Ding; M Elizabeth Deel; Elizabeth A Ferrick; Ronald B Emeson; Martin J Gallagher
Journal:  Neurobiol Dis       Date:  2014-11-04       Impact factor: 5.996

3.  RNA-DNA sequence differences in Saccharomyces cerevisiae.

Authors:  Isabel X Wang; Christopher Grunseich; Youree G Chung; Hojoong Kwak; Girish Ramrattan; Zhengwei Zhu; Vivian G Cheung
Journal:  Genome Res       Date:  2016-09-16       Impact factor: 9.043

Review 4.  The evolution and adaptation of A-to-I RNA editing.

Authors:  Arielle L Yablonovitch; Patricia Deng; Dionna Jacobson; Jin Billy Li
Journal:  PLoS Genet       Date:  2017-11-28       Impact factor: 5.917

Review 5.  Rewriting the transcriptome: adenosine-to-inosine RNA editing by ADARs.

Authors:  Carl R Walkley; Jin Billy Li
Journal:  Genome Biol       Date:  2017-10-30       Impact factor: 13.583

6.  Mutations underlying Episodic Ataxia type-1 antagonize Kv1.1 RNA editing.

Authors:  Elizabeth A Ferrick-Kiddie; Joshua J C Rosenthal; Gregory D Ayers; Ronald B Emeson
Journal:  Sci Rep       Date:  2017-02-20       Impact factor: 4.379

Review 7.  RNA Editing and Retrotransposons in Neurology.

Authors:  Heinz Krestel; Jochen C Meier
Journal:  Front Mol Neurosci       Date:  2018-05-23       Impact factor: 5.639

Review 8.  Adenosine-to-inosine RNA editing in neurological development and disease.

Authors:  Yuxi Yang; Shunpei Okada; Masayuki Sakurai
Journal:  RNA Biol       Date:  2021-01-06       Impact factor: 4.652

9.  K(+) channelepsy: progress in the neurobiology of potassium channels and epilepsy.

Authors:  Maria Cristina D'Adamo; Luigi Catacuzzeno; Giuseppe Di Giovanni; Fabio Franciolini; Mauro Pessia
Journal:  Front Cell Neurosci       Date:  2013-09-13       Impact factor: 5.505

Review 10.  RNA Editing-Systemic Relevance and Clue to Disease Mechanisms?

Authors:  Jochen C Meier; Svenja Kankowski; Heinz Krestel; Florian Hetsch
Journal:  Front Mol Neurosci       Date:  2016-11-23       Impact factor: 5.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.